Sign in

NNOX on Nasdaq

Nano-X Imaging

Logo: nanox.vision3

Nano-X Imaging is a medical imaging systems company based in Petah Tikva, founded in 2018.1 It was founded by Ran Poliakine.1 Its shares trade on Nasdaq under the symbol NNOX.1

Price unavailable

Last updated Oct 21, 2026.

Overview

$13.0MRevenue, fiscal 20254
-$75.0MNet income, fiscal 20254
Dec 2018Founded1

Compare with Butterfly Network, Inc., Hologic or GE HealthCare, or pick any stock.

  • TickerNNOX on Nasdaq1
  • Industrymedical technology industry1
  • HeadquartersPetah Tikva1
  • Websitewww.nanox.vision
  • Incorporated inIsrael5
  • Business addressOfer Tech Park, 94 Shlomo Shmeltzer Road, Petach Tikva, L3 49706025
  • Filer categoryAccelerated filer5

See how the biggest companies compare on our leaderboards

September 3, 2019 and as amended on December 3, 2019 and December 31, 2019, between Nanox Gibraltar and us.6 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

-98.2%Gross margin4
-600.8%Operating margin4
-576.1%Net margin4
15.4%Revenue growth, 20254
-53.7%Return on equity4
-$45.0MFree cash flow4

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

Radiology Services brought in 89% of the revenue Nano-X Imaging broke down this way in fiscal 2025.

  1. Radiology Services$11.6M489%up 13% from 2024
  2. AISolutions$958.0K47%up 32% from 2024
  3. Nanox ARCMember$478.0K44%up 70% from 2024
Business segments by year
Business segments202320242025
Radiology Services$9.5M$10.3M$11.6M
AISolutions$327.0K$727.0K$958.0K
Nanox ARCMember$116.0K$281.0K$478.0K

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue55¢$25.8M
  • Research and development41¢$19.2M
  • Income tax4¢$1.8M

Out of $13.0M in revenue.4 The company lost money this year.

Financial statements

Revenue784$13.0M in 2025+899% since 2021
0$5.0M$10.0M$15.0M2021: $1.3M$1.3M20212022: $8.6M$8.6M2022+558%2023: $9.9M$9.9M2023+15%2024: $11.3M$11.3M2024+14%2025: $13.0M$13.0M2025+15%
Gross profit784-$12.8M in 2025+746% since 2021
-$15.0M-$10.0M-$5.0M02021: -$1.5M-$1.5M20212022: -$6.9M-$6.9M2022+355%2023: -$6.6M-$6.6M2023−4%2024: -$10.6M-$10.6M2024+61%2025: -$12.8M-$12.8M2025+21%
Operating income91011784-$78.2M in 2025+4009% since 2018
-$150.0M-$100.0M-$50.0M02018: -$1.9M-$1.9M20182019: -$22.6M-$22.6M2019+1085%2020: -$43.9M-$43.9M2020+95%2021: -$61.6M-$61.6M2021+40%2022: -$117.7M-$117.7M2022+91%2023: -$62.6M-$62.6M2023−47%2024: -$56.7M-$56.7M2024−9%2025: -$78.2M-$78.2M2025+38%
Net income91011784-$75.0M in 2025+3830% since 2018
-$150.0M-$100.0M-$50.0M02018: -$1.9M-$1.9M20182019: -$22.6M-$22.6M2019+1082%2020: -$43.8M-$43.8M2020+94%2021: -$61.8M-$61.8M2021+41%2022: -$113.2M-$113.2M2022+83%2023: -$60.8M-$60.8M2023−46%2024: -$53.5M-$53.5M2024−12%2025: -$75.0M-$75.0M2025+40%

Every line of the income statement as filed: the last 3 fiscal years, latest first.4

Period ending2025-12-312024-12-312023-12-31
REVENUE$13.0M$11.3M$9.9M
COST OF REVENUE$25.8M$21.9M$16.5M
GROSS LOSS-$12.8M-$10.6M-$6.6M
Research and development, net$19.2M$20.2M$26.0M
Sales and Marketing$5.7M$3.4M$4.2M
General and administrative$21.6M$22.5M$24.3M
Goodwill impairment$7.4M
Change in contingent earnout liability$7.0K-$4.5M
Impairment of long-lived assets$17.5M
Other expenses (income)$1.4M$90.0K-$1.4M
TOTAL OPERATING EXPENSES$65.4M$46.1M$56.0M
OPERATING LOSS-$78.2M-$56.7M-$62.6M
REALIZED INCOME (LOSS) FROM SALE OF MARKETABLE SECURITIES$2.0K-$178.0K
FINANCIAL INCOME, net$1.4M$2.9M$1.7M
OPERATING LOSS BEFORE INCOME TAXES-$76.8M-$53.9M-$61.1M
INCOME TAX BENEFIT$1.8M$358.0K$339.0K
NET LOSS-$75.0M-$53.5M-$60.8M
BASIC LOSS PER SHARE (in Dollars per share)-$1.16-$0.91-$1.08
DILUTED LOSS PER SHARE (in Dollars per share)-$1.16-$0.91-$1.08
WEIGHTED AVERAGE NUMBER OF BASIC ORDINARY SHARES OUTSTANDING (IN THOUSANDS) (in Shares)64.8K shares58.7K shares56.4K shares
WEIGHTED AVERAGE NUMBER OF DILUTED ORDINARY SHARES OUTSTANDING (IN THOUSANDS) (in Shares)64.8K shares58.7K shares56.4K shares
Reclassification of net losses (income) realized in income statement-$2.0K$178.0K
Unrealized gain from marketable securities$1.0K$306.0K$1.5M
Total other comprehensive income:$1.0K$304.0K$1.7M
TOTAL COMPREHENSIVE LOSS-$75.0M-$53.2M-$59.1M

Compare Nano-X Imaging with another company

Corporate structure

Nano-X Imaging sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Nano-X Imaging

  • BlackRock Filed SCHEDULE 13G/A on Nano-X Imaging, latest Jul 29, 2026 (5 filings since Feb 6, 2024)
  • Moshe Moalem Filed SCHEDULE 13G/A on Nano-X Imaging, latest Jul 15, 2026 (2 filings since Dec 21, 2021)
  • SK Square Filed SCHEDULE 13G/A on Nano-X Imaging, latest May 15, 2026 (2 filings since Feb 14, 2022)
  • Ran Poliakine Filed SC 13G/A on Nano-X Imaging, latest Feb 14, 2023 (2 filings since Feb 14, 2022)
  • Richard B. Stone Filed SC 13G/A on Nano-X Imaging, latest Feb 14, 2022
  • SK Telecom Filed SC 13G/A on Nano-X Imaging, latest Feb 14, 2022
  • Nano-X Imaging Petah Tikva

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Nano-X Imaging reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$35.3M4 Dec 31, 2025$51.0M4 Dec 31, 2024−30.8%
Accumulated depreciation$5.6M4 Dec 31, 2025$5.7M4 Dec 31, 2024−1.0%
Property and equipment, net$29.7M4 Dec 31, 2025$45.4M4 Dec 31, 2024−34.6%
Operating-lease assets (leased space)$3.5M4 Dec 31, 2025$3.8M4 Dec 31, 2024−8.5%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$49.2M4 Dec 31, 2025$39.3M4 Dec 31, 2024+25.1%
Marketable securities, current$18.4M4 Dec 31, 2024$26.0M8 Dec 31, 2023−29.2%
Debt securities available for sale$18.4M4 Dec 31, 2024$26.0M8 Dec 31, 2023−29.2%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$316.0K4 Dec 31, 2025$7.4M4 Dec 31, 2022−95.7%
Finite-lived intangibles, gross$104.0M4 Dec 31, 2025$103.6M4 Dec 31, 2024+0.4%
Accumulated amortization$44.1M4 Dec 31, 2025$33.6M4 Dec 31, 2024+31.3%
Finite-lived intangibles, net$59.9M4 Dec 31, 2025$70.0M4 Dec 31, 2024−14.5%

Inventory

ItemLatestA year beforeChange
Inventory, total$3.1M4 Dec 31, 2025$1.5M4 Dec 31, 2024+105.6%
Finished goods$1.7M4 Dec 31, 2025$685.0K4 Dec 31, 2024+152.4%

The story

Founded by Ran Poliakine on Dec 2018.1

Leadership

Who has led Nano-X Imaging, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Erez Meltzer2026–now

Chief financial officer

  1. Ran Bendaniel2025–2026
  2. Guy Nathansohn2026–now
20202025
Board members and other officers (12)

Timeline

  1. Mar 18, 2026New chief executive Erez Meltzer becomes CEO12
  2. Dec 2018Founded Founded1

Calendar

Coming up

  1. Nov 19, 2026Reports results for the quarter ending Sep/2026 A year earlier it reported ($0.65) a share, on Nov 20, 2025.26

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

153 filings to the SEC since October 2021: 5 annual reports, 32 insider forms, 13 large holders, 103 other. The latest 20:

  1. Oct 14, 20264 EDGAR
  2. Oct 14, 20264 EDGAR
  3. Oct 14, 20264 EDGAR
  4. Oct 14, 20264 EDGAR
  5. Oct 13, 20264 OWNERSHIP DOCUMENT EDGAR
  6. Oct 13, 20264 EDGAR
  7. Oct 13, 20264 EDGAR
  8. Oct 2, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  9. Sep 29, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  10. Sep 17, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  11. Sep 16, 20264 EDGAR
  12. Sep 15, 20264 EDGAR
  13. Sep 14, 20264 EDGAR
  14. Sep 9, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  15. Aug 18, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  16. Aug 13, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  17. Aug 11, 20264 EDGAR
  18. Aug 7, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  19. Aug 7, 2026424B5 PROSPECTUS SUPPLEMENT EDGAR
  20. Aug 6, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR

The 153 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

9 open-market trades by officers, directors and large owners since October 2021: 8 buys and 1 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Sep 15, 2026Meltzer ErezChief Executive OfficerBuy10,000$0.69$6.9KForm 4
Sep 14, 2026Suesskind Dan SDirectorBuy60,000$0.76$45.3KForm 4
Sep 10, 2026Meltzer ErezChief Executive OfficerBuy10,000$0.78$7.8KForm 4
Aug 10, 2026Meltzer ErezChief Executive OfficerBuy9,443$1.03$9.7KForm 4
Jul 28, 2026Kainan NogaDirectorBuy33,000$0.90$29.7KForm 4
Jul 27, 2026Suesskind Dan SDirectorBuy50,000$0.93$46.5KForm 4
Jul 27, 2026Meltzer ErezChief Executive OfficerBuy36,000$0.93$33.5KForm 4
Jun 10, 2026Alroy ErezDirectorSale678$1.65$1.1KForm 4
Sep 5, 2025Daniel RanCFOBuy1,000$3.65$3.6KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

  • BlackRockSCHEDULE 13G/A, 5 filings Feb 6, 2024 to Jul 29, 202627
  • Moshe MoalemSCHEDULE 13G/A, 2 filings Dec 21, 2021 to Jul 15, 202628
  • SK SquareSCHEDULE 13G/A, 2 filings Feb 14, 2022 to May 15, 202629
  • Ran PoliakineSC 13G/A, 2 filings Feb 14, 2022 to Feb 14, 202330
  • Richard B. StoneSC 13G/A, 1 filing Feb 14, 202231
  • SK TelecomSC 13G/A, 1 filing Feb 14, 202232

SEC filer profile

How Nano-X Imaging is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARNano-X Imaging Ltd.2
  • CIK0001795251
  • Filer statusAccelerated filer not an emerging growth company; not a shell company6
  • Incorporated inIsrael6
  • Fiscal year endsDecember 312
  • Industry code (SIC)3844 X-Ray Apparatus & Tubes & Related Irradiation Apparatus2
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance2
  • Business addressOfer Tech Park, 94 Shlomo Shmeltzer Road, Petach Tikva, L3 49706022
  • Phone972-373592022
  • Shares outstanding69,590,228 shares as of Dec 31, 20256
  • AuditorKesselman & Kesselman, Tel Aviv PCAOB ID 1309; it also attests to the company’s internal control over financial reporting6
  • On EDGAR sinceDec 4, 20192
  • Filings209 in all: 6-K (95), 4 (18), 3 (14), UPLOAD (10), CORRESP (9), SC 13G (9), 20-F (6), SC 13G/A (6)2
    All 29 form types

    424B5 (5), EFFECT (4), DRS/A (3), DRSLTR (3), F-1/A (3), SCHEDULE 13G/A (3), 144 (2), 424B4 (2), DRS (2), F-1 (2), F-3 (2), POSASR (2), 6-K/A (1), 8-A12B (1), CERT (1), F-1MEF (1), F-3/A (1), F-3ASR (1), POS AM (1), RW (1), S-8 (1)

  • Latest filingsAnnual report (20-F) Apr 30, 2026

Securities registered for trading

ClassSymbolExchange
Ordinary Shares, par value NIS 0.01 per shareNNOXThe NASDAQ Stock Market LLC

From the cover page of the 20-F filed Apr 30, 2026 (Section 12(b) of the Exchange Act).6

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
    Company websiteNano-X Imaging logo
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32